Fotivda (Indications)

In this article, we will discuss Fotivda (Indications). So, let’s get started.

Therapeutic Indications

Fotivda is indicated for the first line treatment of adult patients with advanced renal cell carcinoma (RCC) and for adult patients who are VEGFR and mTOR pathway inhibitor-naïve following disease progression after one prior treatment with cytokine therapy for advanced RCC.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.